ASCO 2021: VISION Shows Addition of 177Lutetium-Labeled Prostate-Specific Membrane Antigen Improves Outcomes in Advanced Prostate Cancer
Pending regulatory approval, this could become a novel treatment approach
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.